Stockscreener 앱 받기
1.42
5.33%
-0.08
시간 외 거래:
1.44
0.02
+1.41%
전일 마감가:
$1.50
열려 있는:
$1.43
하루 거래량:
554.03K
Relative Volume:
0.70
시가총액:
$69.65M
수익:
$134.60K
순이익/손실:
$-11.81M
주가수익비율:
-5.8946
EPS:
-0.2409
순현금흐름:
$-10.05M
1주 성능:
+17.36%
1개월 성능:
+10.94%
6개월 성능:
-5.96%
1년 성능:
-15.48%
1일 변동 폭
$1.42
$1.47
1주일 범위
$1.168
$1.96
52주 변동 폭
$1.13
$2.55
Medicinova Inc Stock (MNOV) Company Profile
명칭
Medicinova Inc
전화
858-373-1500
주소
4275 EXECUTIVE SQUARE, LA JOLLA, CA
MNOV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.42 | 73.57M | 134.60K | -11.81M | -10.05M | -0.2409 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-10 | 개시 | Maxim Group | Buy |
| 2019-03-25 | 재개 | B. Riley FBR | Buy |
| 2018-03-28 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-04-18 | 개시 | Credit Suisse | Outperform |
| 2013-01-04 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-05-24 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2011-10-18 | 재확인 | MLV Capital | Buy |
| 2011-06-22 | 개시 | Global Hunter Securities | Buy |
| 2010-05-12 | 개시 | Wedbush | Outperform |
| 2008-11-12 | 재확인 | Ladenburg Thalmann | Buy |
| 2008-05-15 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-07-09 | 개시 | Punk, Ziegel & Co | Buy |
모두보기
Medicinova Inc 주식(MNOV)의 최신 뉴스
How currency fluctuations impact MediciNova Inc. stockWeekly Investment Summary & Stock Timing and Entry Methods - newser.com
MNOV: Analyst Reaffirms Buy Rating at $9.00 Target Price | MNOV Stock News - GuruFocus
MediciNova completes patient enrollment in MN-001 trial for tipelukast in MN-001-NATG-202 study - MarketScreener
MediciNova (NASDAQ: MNOV) completes Phase 2 MN-001 enrollment – topline data summer 2026 - Stock Titan
Is MediciNova Inc. stock a contrarian buyPortfolio Return Report & Weekly High Momentum Picks - newser.com
Trend analysis for MediciNova Inc. this weekPortfolio Growth Summary & Weekly Top Gainers Trade List - newser.com
What Fibonacci levels say about MediciNova Inc. rebound2025 AllTime Highs & Safe Entry Point Alerts - newser.com
What’s next for MediciNova Inc. stock priceWeekly Risk Summary & Step-by-Step Trade Execution Guides - newser.com
Market reaction to MediciNova Inc.’s recent news2025 Top Decliners & Risk Controlled Daily Plans - newser.com
MediciNova (NASDAQ:MNOV) Share Price Passes Above 200-Day Moving AverageTime to Sell? - MarketBeat
Will MediciNova Inc. stock maintain growth story2025 Technical Overview & Safe Capital Growth Tips - newser.com
Key resistance and support levels for MediciNova Inc.July 2025 Analyst Calls & Growth Focused Investment Plans - newser.com
Applying big data sentiment scoring on MediciNova Inc.July 2025 Setups & Free Accurate Trade Setup Notifications - newser.com
What dividend safety score for MediciNova Inc. stockStop Loss & Momentum Based Trading Signals - newser.com
3 Penny Stocks With Market Caps Over $80M To Consider - simplywall.st
Applying Elliott Wave Theory to MediciNova Inc.Trend Reversal & Weekly Setup with High ROI Potential - newser.com
Will MediciNova Inc. stock remain a Wall Street favorite2025 Stock Rankings & Weekly Breakout Stock Alerts - newser.com
Developing predictive dashboards with MediciNova Inc. dataWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
MediciNova Research Sparks New Hope for Atherosclerosis Therapy - StocksToTrade
MediciNova’s Breakthrough Strategy in Atherosclerosis Treatment - timothysykes.com
MediciNova, Inc. (MNOV) Stock Price, News, Quote & History - Yahoo! Finance Canada
MediciNova Stock Rockets 85% After-Hours On Promising Heart Study — Traders Hope For ‘Big Green Candle’ - Stocktwits
Will MediciNova Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Verified Technical Signals - newser.com
MediciNova Advances Atherosclerosis Research with Novel Therapeutic Strategy - StocksToTrade
MediciNova’s New Research Drives Strategic Focus on Cholesterol Metabolism - timothysykes.com
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis - Yahoo Finance
MediciNova Stock Surge: Unveiling the Latest Development - timothysykes.com
MediciNova (MNOV) Analyst Ratings: Consistent 'Buy' Rating Maint - GuruFocus
D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation - Nasdaq
Medicinova Inc (MNOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):